Development of a multi-epitope peptide vaccine against human leishmaniases

Development of a multi-epitope peptide vaccine against human leishmaniases

La leishmaniose est une maladie tropicale négligée à transmission vectorielle qui est endémique dans 98 pays dont les plus pauvres. Vingt espèces de Leishmania sont capables d’établir une infection intracellulaire au sein des macrophages humains, provoquant différentes manifestations cliniques. Le d...

Full description

Bibliographic Details
Main Author:	Da Silva Pissarra, Joana
Other Authors:	Montpellier
Language:	en
Published:	2019
Subjects:	Leishmania Vaccin Peptidique Vaccine Peptide-Based
Online Access:	http://www.theses.fr/2019MONTT013/document

Similar Items

Immunogenicity of MHC Class I Peptides Derived from Leishmania Mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models
by: H Rezvan, et al.
Published: (2012-12-01)

Immunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models
by: H. Rezvan, et al.
Published: (2015-10-01)

Vaccines against Leishmania
by: Martínez-Silva, Elisa, et al.
Published: (2016-04-01)

Leishmania vaccines entered in clinical trials: A review of literature
by: Mohammad Moafi, et al.
Published: (2019-01-01)

Leishmanolysin gp63: Bioinformatics evidences of immunogenic epitopes in Leishmania major for enhanced vaccine design against zoonotic cutaneous leishmaniasis
by: Morteza Shams, et al.
Published: (2021-01-01)

Adjuvants for Leishmania vaccines: From Models to Clinical Application
by: Vanitha S. Raman, et al.
Published: (2012-06-01)

Kinetoplastid membrane protein-11 as a vaccine candidate and a virulence factor in Leishmania
by: Sergio Coutinho Furtado De Mendonça, et al.
Published: (2015-10-01)

The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia
by: R. Lainson, et al.
Published: (1994-09-01)

Leishmaniasis vaccine: Where are we today?
by: Lukasz Kedzierski
Published: (2010-01-01)

Cutaneous Leishmaniasis Vaccination: A Matter of Quality
by: Paula Mello De Luca, et al.
Published: (2016-04-01)

Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
by: Malcolm S. Duthie, et al.
Published: (2018-10-01)

PREPARATION OF KILLED LEISHMANIA VACCINE AND ITS EVALUATION FOR CONTROL OF VISCERAL LEISHMANIASIS IN DOGS
by: M.Mohebali, et al.
Published: (1998-09-01)

The Use of Specific Serological Biomarkers to Detect CaniLeish Vaccination in Dogs
by: Carla Lima, et al.
Published: (2019-10-01)

Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production
by: Rafaella FQ Grenfell, et al.
Published: (2010-09-01)

Role of imiquimod as adjuvant for vaccination against Leishmania major infection in BALB/c mice
by: Faramarz Dobakhti, et al.
Published: (2013-11-01)

The Delay in the Licensing of Protozoal Vaccines: A Comparative History
by: Clarisa Beatriz Palatnik-de-Sousa, et al.
Published: (2020-03-01)

Design, Construction and Immunogenicity Assessment of pEGFP-N1-KMP11-GP96 (Fusion) as a DNA Vaccine Candidate against Leishmania major Infection in BALB/c Mice
by: Abdolhossein DALIMI, et al.
Published: (2020-03-01)

In silico analysis and expression of a new chimeric antigen as a vaccine candidate against cutaneous leishmaniasis
by: Leila Motamedpour, et al.
Published: (2020-11-01)

Post-Genomics and Vaccine Improvement for Leishmania
by: Negar eSeyed, et al.
Published: (2016-04-01)

Designing a DNA Vaccine-based Leishmania major Polytope (Preliminary Report)
by: Shabnam JEIBOUEI, et al.
Published: (2017-09-01)

Avaliação das histonas de L. infantum como candidatos à vacinas na infecção por l.infantum em hamsters
by: Pereira, Laís da Silva
Published: (2013)

Innate Immunity Plays a Key Role in Leishmania Infection: Implications for Vaccine Design
by: Negar Seyed, et al.
Published: (2016-07-01)

Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects
by: Ana Paula FERNANDES, et al.
Published: (1997-03-01)

Vaccine development against Leishmania donovani
by: Amrita eDas, et al.
Published: (2012-05-01)

A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis
by: Evita Athanasiou, et al.
Published: (2017-06-01)

A Novel Chimeric Antigen as a Vaccine Candidate against Leishmania major: In silico Analysis
by: Niloofar Bavarsad Ahmadpour, et al.
Published: (2021-05-01)

Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis
by: Javier Moreno
Published: (2019-06-01)

DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers
by: Amin Daemi, et al.
Published: (2014-08-01)

Epitope Selection for Fighting Visceral Leishmaniosis: Not All Peptides Function the Same Way
by: Abel Martínez-Rodrigo, et al.
Published: (2020-07-01)

Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum
by: Alba Martínez-Flórez, et al.
Published: (2020-06-01)

Evaluation of novel anti-tumoral strategies using peptide or monoclonal antibody immunotherapies
by: Mustapha, Rami
Published: (2016)

Canines vaccinated against visceral leishmaniasis develop a serological response to the Leishmania braziliensis antigen
by: Julia de Assis Pinheiro, et al.
Published: (2018-03-01)

Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice
by: Rory Cristiane Fortes De Brito, et al.
Published: (2019-10-01)

Vaccination of C57BL/10 mice against cutaneous leishmaniasis using killed promastigotes of different strains and species of Leishmania Vacinação de camundongos C57BL/10 contra leishmaniose com promastigotas mortas de diferentes cepas e espécies de Leishmania
by: Wilson Mayrink, et al.
Published: (2002-04-01)

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis
by: Noushin eSaljoughian, et al.
Published: (2014-03-01)

Avaliação da resposta imune celular desencadeada por antígenos protéicos isolados de Leishmania (Viannia) shawi
by: Luiz Felipe Domingues Passero
Published: (2011)

Avaliação da resposta imune celular desencadeada por antígenos protéicos isolados de Leishmania (Viannia) shawi
by: Passero, Luiz Felipe Domingues
Published: (2011)

Leishmaniases in the European Union and Neighboring Countries
by: Eduardo Berriatua, et al.
Published: (2021-06-01)

Construction of Epitope-Based Peptide Vaccine Against SARS-CoV-2: Immunoinformatics Study
by: Viol Dhea Kharisma, et al.
Published: (2020-05-01)

Search for Surrogate Marker(s) of Immunity Following Vaccination with Experimental Vaccine (Autoclaved Leishmania Major + Bacille Calmette-Guérin) in Human Volunteers
by: Mahmoodi, Majid
Published: (1998)